New

Monoamine Oxidase Inhibitor Market

2021

Monoamine Oxidase Inhibitor Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Nonselective MAO-A/MAO-B Inhibitors, and Selective MAO-A/MAO-B Inhibitors); Application (Atypical Depression Treatment, Parkinson's Disease Treatment, and Other Therapies), and Geography

| Report Code: TIPRE00018833 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Monoamine Oxidase Inhibitor Market 2028 By Type, Application, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Monoamine oxidase inhibitors (MAOI) are drugs which help to inhibit the activity of monoamine oxidase enzymes A and B. These are used in the treatment of anxiety, depression, Parkinson's disease, dysthymia, and other type of disorders. These are the first type of manufactured antidepressant drugs. These drugs have the availability to remove dopamine, neurotransmitters serotonin, and norepinephrine from the brain. These drugs require certain diet restrictions as they effect blood pressure of patients when taken with other prescribed patients.

MARKET DYNAMICS

Factors driving the growth of the monoamine oxidase inhibitor market are the presence of large population base suffering from anxiety, and growing awareness among the population regarding mental health. However, patent expiry and, the side-effects associated with MAOI's is likely to hamper the growth of this market.

MARKET SCOPE

The "Monoamine Oxidase Inhibitor Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of monoamine oxidase inhibitor market with detailed market segmentation by type, and application. The monoamine oxidase inhibitor market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in monoamine oxidase inhibitor market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The monoamine oxidase inhibitor market is segmented on the basis of type, and application. On the basis of type, the market is categorized as Nonselective MAO-A MAO-B inhibitors, and selective MAO-A/ MAO-B inhibitors. On the basis of application the market is categorized as atypical depression treatment, Parkinson's disease treatment, and other therapies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the monoamine oxidase inhibitor market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The monoamine oxidase inhibitor market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting monoamine oxidase inhibitor market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the monoamine oxidase inhibitor market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the monoamine oxidase inhibitor market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from monoamine oxidase inhibitor market are anticipated to have lucrative growth opportunities in the future with the rising demand for monoamine oxidase inhibitor in the global market. Below mentioned is the list of few companies engaged in the monoamine oxidase inhibitor market.

The report also includes the profiles of key players in monoamine oxidase inhibitor market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.
- Novartis
- Pfizer, Inc.
- Validus Pharmaceuticals LLC
- Eli Lilly and Company
- GlaxoSmithKline
- Merck & Co.
- Concordia Pharms, Inc.
- Takeda Pharmaceutical Company Limited
- Mylan N.V.
- Bristol-Myers Squibb Company
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Monoamine Oxidase Inhibitor Market - By Type
1.3.2 Monoamine Oxidase Inhibitor Market - By Application
1.3.3 Monoamine Oxidase Inhibitor Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MONOAMINE OXIDASE INHIBITOR MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MONOAMINE OXIDASE INHIBITOR MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MONOAMINE OXIDASE INHIBITOR MARKET - GLOBAL MARKET ANALYSIS
6.1. MONOAMINE OXIDASE INHIBITOR - GLOBAL MARKET OVERVIEW
6.2. MONOAMINE OXIDASE INHIBITOR - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. MONOAMINE OXIDASE INHIBITOR MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. NONSELECTIVE MAO-A/MAO-B INHIBITORS
7.3.1. Overview
7.3.2. Nonselective MAO-A/MAO-B Inhibitors Market Forecast and Analysis
7.4. SELECTIVE MAO-A/MAO-B INHIBITORS
7.4.1. Overview
7.4.2. Selective MAO-A/MAO-B Inhibitors Market Forecast and Analysis
8. MONOAMINE OXIDASE INHIBITOR MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ATYPICAL DEPRESSION TREATMENT
8.3.1. Overview
8.3.2. Atypical Depression Treatment Market Forecast and Analysis
8.4. PARKINSON'S DISEASE TREATMENT
8.4.1. Overview
8.4.2. Parkinson's Disease Treatment Market Forecast and Analysis
8.5. OTHER THERAPIES
8.5.1. Overview
8.5.2. Other Therapies Market Forecast and Analysis
9. MONOAMINE OXIDASE INHIBITOR MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Monoamine Oxidase Inhibitor Market Overview
9.1.2 North America Monoamine Oxidase Inhibitor Market Forecasts and Analysis
9.1.3 North America Monoamine Oxidase Inhibitor Market Forecasts and Analysis - By Type
9.1.4 North America Monoamine Oxidase Inhibitor Market Forecasts and Analysis - By Application
9.1.5 North America Monoamine Oxidase Inhibitor Market Forecasts and Analysis - By Countries
9.1.5.1 United States Monoamine Oxidase Inhibitor Market
9.1.5.1.1 United States Monoamine Oxidase Inhibitor Market by Type
9.1.5.1.2 United States Monoamine Oxidase Inhibitor Market by Application
9.1.5.2 Canada Monoamine Oxidase Inhibitor Market
9.1.5.2.1 Canada Monoamine Oxidase Inhibitor Market by Type
9.1.5.2.2 Canada Monoamine Oxidase Inhibitor Market by Application
9.1.5.3 Mexico Monoamine Oxidase Inhibitor Market
9.1.5.3.1 Mexico Monoamine Oxidase Inhibitor Market by Type
9.1.5.3.2 Mexico Monoamine Oxidase Inhibitor Market by Application
9.2. EUROPE
9.2.1 Europe Monoamine Oxidase Inhibitor Market Overview
9.2.2 Europe Monoamine Oxidase Inhibitor Market Forecasts and Analysis
9.2.3 Europe Monoamine Oxidase Inhibitor Market Forecasts and Analysis - By Type
9.2.4 Europe Monoamine Oxidase Inhibitor Market Forecasts and Analysis - By Application
9.2.5 Europe Monoamine Oxidase Inhibitor Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Monoamine Oxidase Inhibitor Market
9.2.5.1.1 Germany Monoamine Oxidase Inhibitor Market by Type
9.2.5.1.2 Germany Monoamine Oxidase Inhibitor Market by Application
9.2.5.2 France Monoamine Oxidase Inhibitor Market
9.2.5.2.1 France Monoamine Oxidase Inhibitor Market by Type
9.2.5.2.2 France Monoamine Oxidase Inhibitor Market by Application
9.2.5.3 Italy Monoamine Oxidase Inhibitor Market
9.2.5.3.1 Italy Monoamine Oxidase Inhibitor Market by Type
9.2.5.3.2 Italy Monoamine Oxidase Inhibitor Market by Application
9.2.5.4 Spain Monoamine Oxidase Inhibitor Market
9.2.5.4.1 Spain Monoamine Oxidase Inhibitor Market by Type
9.2.5.4.2 Spain Monoamine Oxidase Inhibitor Market by Application
9.2.5.5 United Kingdom Monoamine Oxidase Inhibitor Market
9.2.5.5.1 United Kingdom Monoamine Oxidase Inhibitor Market by Type
9.2.5.5.2 United Kingdom Monoamine Oxidase Inhibitor Market by Application
9.2.5.6 Rest of Europe Monoamine Oxidase Inhibitor Market
9.2.5.6.1 Rest of Europe Monoamine Oxidase Inhibitor Market by Type
9.2.5.6.2 Rest of Europe Monoamine Oxidase Inhibitor Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Monoamine Oxidase Inhibitor Market Overview
9.3.2 Asia-Pacific Monoamine Oxidase Inhibitor Market Forecasts and Analysis
9.3.3 Asia-Pacific Monoamine Oxidase Inhibitor Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Monoamine Oxidase Inhibitor Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Monoamine Oxidase Inhibitor Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Monoamine Oxidase Inhibitor Market
9.3.5.1.1 Australia Monoamine Oxidase Inhibitor Market by Type
9.3.5.1.2 Australia Monoamine Oxidase Inhibitor Market by Application
9.3.5.2 China Monoamine Oxidase Inhibitor Market
9.3.5.2.1 China Monoamine Oxidase Inhibitor Market by Type
9.3.5.2.2 China Monoamine Oxidase Inhibitor Market by Application
9.3.5.3 India Monoamine Oxidase Inhibitor Market
9.3.5.3.1 India Monoamine Oxidase Inhibitor Market by Type
9.3.5.3.2 India Monoamine Oxidase Inhibitor Market by Application
9.3.5.4 Japan Monoamine Oxidase Inhibitor Market
9.3.5.4.1 Japan Monoamine Oxidase Inhibitor Market by Type
9.3.5.4.2 Japan Monoamine Oxidase Inhibitor Market by Application
9.3.5.5 Rest of Asia-Pacific Monoamine Oxidase Inhibitor Market
9.3.5.5.1 Rest of Asia-Pacific Monoamine Oxidase Inhibitor Market by Type
9.3.5.5.2 Rest of Asia-Pacific Monoamine Oxidase Inhibitor Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Monoamine Oxidase Inhibitor Market Overview
9.4.2 Middle East and Africa Monoamine Oxidase Inhibitor Market Forecasts and Analysis
9.4.3 Middle East and Africa Monoamine Oxidase Inhibitor Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Monoamine Oxidase Inhibitor Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Monoamine Oxidase Inhibitor Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Monoamine Oxidase Inhibitor Market
9.4.5.1.1 South Africa Monoamine Oxidase Inhibitor Market by Type
9.4.5.1.2 South Africa Monoamine Oxidase Inhibitor Market by Application
9.4.5.2 Saudi Arabia Monoamine Oxidase Inhibitor Market
9.4.5.2.1 Saudi Arabia Monoamine Oxidase Inhibitor Market by Type
9.4.5.2.2 Saudi Arabia Monoamine Oxidase Inhibitor Market by Application
9.4.5.3 U.A.E Monoamine Oxidase Inhibitor Market
9.4.5.3.1 U.A.E Monoamine Oxidase Inhibitor Market by Type
9.4.5.3.2 U.A.E Monoamine Oxidase Inhibitor Market by Application
9.4.5.4 Rest of Middle East and Africa Monoamine Oxidase Inhibitor Market
9.4.5.4.1 Rest of Middle East and Africa Monoamine Oxidase Inhibitor Market by Type
9.4.5.4.2 Rest of Middle East and Africa Monoamine Oxidase Inhibitor Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Monoamine Oxidase Inhibitor Market Overview
9.5.2 South and Central America Monoamine Oxidase Inhibitor Market Forecasts and Analysis
9.5.3 South and Central America Monoamine Oxidase Inhibitor Market Forecasts and Analysis - By Type
9.5.4 South and Central America Monoamine Oxidase Inhibitor Market Forecasts and Analysis - By Application
9.5.5 South and Central America Monoamine Oxidase Inhibitor Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Monoamine Oxidase Inhibitor Market
9.5.5.1.1 Brazil Monoamine Oxidase Inhibitor Market by Type
9.5.5.1.2 Brazil Monoamine Oxidase Inhibitor Market by Application
9.5.5.2 Argentina Monoamine Oxidase Inhibitor Market
9.5.5.2.1 Argentina Monoamine Oxidase Inhibitor Market by Type
9.5.5.2.2 Argentina Monoamine Oxidase Inhibitor Market by Application
9.5.5.3 Rest of South and Central America Monoamine Oxidase Inhibitor Market
9.5.5.3.1 Rest of South and Central America Monoamine Oxidase Inhibitor Market by Type
9.5.5.3.2 Rest of South and Central America Monoamine Oxidase Inhibitor Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MONOAMINE OXIDASE INHIBITOR MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MONOAMINE OXIDASE INHIBITOR MARKET, KEY COMPANY PROFILES
12.1. NOVARTIS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. VALIDUS PHARMACEUTICALS LLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ELI LILLY AND COMPANY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLAXOSMITHKLINE
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK & CO.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CONCORDIA PHARMS, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MYLAN N.V.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BRISTOL-MYERS SQUIBB COMPANY
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Novartis
2. Pfizer, Inc.
3. Validus Pharmaceuticals LLC
4. Eli Lilly and Company
5. GlaxoSmithKline
6. Merck & Co.
7. Concordia Pharms, Inc.
8. Takeda Pharmaceutical Company Limited
9. Mylan N.V.
10. Bristol-Myers Squibb Company
TIPRE00018833
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.